REMS Combined With TAI for Unresectable HC

NACompletedINTERVENTIONAL

Enrollment

126

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

July 15, 2023

Study Completion Date

July 15, 2023

Conditions

Unresectable Hilar Cholangiocarcinoma

Interventions

PROCEDURE

REMS+TAI

Radiation-Emitting Metallic Stents (REMS) Combined With Trans-Arterial Infusion (TAI) for Unresectable Hilar Cholangiocarcinoma

PROCEDURE

SEMS+TAI

Uncovered Self-Expandable Metallic Stent (SEMS) Combined With Trans-Arterial Infusion (TAI) for Unresectable Hilar Cholangiocarcinoma

Trial Locations (1)

Zhongda Hospital,Southeast University, Nanjing

All Listed Sponsors

lead

Zhongda Hospital

OTHER

NCT04801160 - REMS Combined With TAI for Unresectable HC | Biotech Hunter | Biotech Hunter